baber/WOPTO huggingface dataset:
Patent AU-2004200553-B2 (AU)
Title: Temperature controlled dispensing device
Inventor: GUTIERREZ J ANTONIO
IPC: B67D1/08
Filed: 2004-02-12
Granted: 2010-04-22
Abstract: A flowable food dispenser (20) for dispensing a flowable food product. The dispenser includes a housing (22) with first and second bays (36,37), and a plurality of cassettes (40) that are removably receivable within the bays. Each cassette is configured for receiving a pouch (72) containing the flowable food. First and second thermal exchange units (80) are associated with the first and second bays, respectively, in heat-exchanging association with the cassettes received therein. A temperature-controlled system (90) is connected with the thermal exchange units for controlling them independently to independently heat or cool the cassettes in the bays and the food product that is disposed therein. A least one dispensing mechanism (106) is associated with the first and second bays to selectively dispense the food from the pouches that are in the cassettes. <IMAGE>
Patent AU-2004249301-B2 (AU)
Title: Methods for hyperthyroidism in a cat and composition comprising limited iodine
Inventor: KIRK CLAUDIA ANN
IPC: A23K20/195
Filed: 2004-06-18
Granted: 2011-01-20
Abstract: Dietary compositions and methods for restoring normal thyroid function in a feline having hyperthyroidism to a more nearly normal state are disclosed. The compositions and methods restrict the amount of iodine intake in the feline.
Patent AU-2004280973-B2 (AU)
Title: System, method and apparatus for enabling transactions using a biometrically enabled programmable magnetic stripe
Inventor: ANTAKI PATRICK R
IPC: G06F/
Filed: 2004-10-07
Granted: 2011-09-01
Abstract: The present invention provides a system, method and apparatus that includes a user device having a magnetic field generator (308) disposed within a substrate that is normally inactive, a biometric sensor (310) mounted on the substrate, a memory (312) disposed within the substrate and a processor (314) disposed within the substrate that is communicably coupled to the magnetic field generator (308), the biometric sensor (310) and the memory (312). The processor (314) is operable to process biometric information received from the biometric sensor (310) to verify that a user is authorized to use the apparatus and activate the magnetic field generator (308) when the user is verified. A power source (316) is also disposed within the substrate. The magnetic field generator (308) can create a spatially varying magnetic signal using a magnetic stripe and one or more induction coils, or create a time-varying magnetic signal for emulating data obtained from swiping a magnetic stripe card through a magnetic card reader (330).
Patent AU-2006200266-B2 (AU)
Title: Herbicidal composition
Inventor: WATANABE ATSUSHI
IPC: A01N35/10
Filed: 2006-01-20
Granted: 2011-07-28
Abstract: Abstract A dehydration step provides a good storage stability to clethodium formulation. A herbicidal composition comprising clethodim as an active ingredient, wherein the content of water in the herbicidal composition is less than approximately 0.20% by weight provides a good storage stability of the clethodim in the composition.
Patent AU-2006247595-B2 (AU)
Title: Dynamic tensioning system and method
Inventor: O'MALLEY MICHAEL T
IPC: A61B17/08
Filed: 2006-05-12
Granted: 2012-02-09
Abstract: Systems and methods of applying dynamic force to tissues to promote healing. Systems of this invention may be applied to tissue to bolster the tissues, move the tissues, or expand the tissue. Systems of this invention may also include a tension indication feature, allowing measured application of dynamic force to the tissue.
Patent AU-2006285181-B2 (AU)
Title: Fiber optic universal bracket apparatus
Inventor: JOHNSON JOHN B
IPC: G02B6/44
Filed: 2006-08-22
Granted: 2012-01-19
Abstract: A bracket assembly includes a bracket including a flexible hinge, and a furcation assembly attached to the bracket.
Patent AU-2006303820-B2 (AU)
Title: Cereals with altered dormancy
Inventor: GUBLER FRANZ JACQUES MARIE
IPC: A23L7/10
Filed: 2006-10-19
Granted: 2013-06-20
Abstract: The present invention relates to polypeptides, and polynucleotides encoding therefor, which influence seed dormancy in cereals such as wheat and barley. In particular, the present invention relates to polypeptides with ABA 8'-hydroxylase activity, and polynucleotides encoding these proteins. Also provided are cereal plants which produce seeds that have altered rates of germination, and/or levels of dormancy, when compared to seeds from wild-type plants, as well as methods of producing such plants.
Patent AU-2006313318-B2 (AU)
Title: Improved variants of pigment epithelium derived factor and uses thereof
Inventor: MAIK-RACHLINE GALIA
IPC: C07K14/00
Filed: 2006-11-14
Granted: 2012-04-05
Abstract: The present invention relates to anti-angiogenic variants of pigment epithelium derived factor (PEDF) comprising a plurality of altered phosphorylation sites, polynucleotides encoding same and uses thereof. In particular, the PEDF variants of the present invention provide superior anti-angiogenic activity and high neurotrophic activity and are useful in treating diseases associated with neovascularization and with neurodegenerative conditions.
Patent AU-2006325975-B2 (AU)
Title: Nuclear reprogramming factor
Inventor: SHINYA YAMANAKA
IPC: A61L27/38
Filed: 2006-12-06
Granted: 2011-12-08
Abstract: Disclosed is a means for inducing the reprogramming of a differentiated cell without using any embryo or ES cell and establish an inducible pluripotent stem cell having similar pluripotency and growing ability to those of an ES cell in a simple manner and with good reproductivity. As the means, a nuclear reprogramming factor for a somatic cell is provided, which comprise products of the following three genes: an Oct family gene; a Klf family gene; and an Myc family gene.
Patent AU-2007214294-B2 (AU)
Title: Sidewall construction of a casting mold
Inventor: VAPPULA KARI
IPC: B28B7/00
Filed: 2007-08-29
Granted: 2011-07-28
Abstract: A sidewall construction for casting concrete elements, said sidewall construction comprising a mold surface plate (4) defining the surface of the product to be cast and a support construction (1, 2, 3), where the mold surface plate is fixed to, whereby the support construction is formed of two horizontal aluminium profiles (1, 2) and of at least one vertical aluminium profile (3) connecting the same.
Patent AU-2007214689-B2 (AU)
Title: Method for improving dog food
Inventor: BOUTHEGOURD JEAN-CHRISTOPHE
IPC: A23K1/18
Filed: 2007-02-16
Granted: 2012-05-24
Abstract: Methods for preparing dog food compositions adapted for dogs with certain body conformation types by categorizing a dog for which the food composition is intended as a robust or athletic body conformation type and formulating a dog food composition to contain feed ingredients beneficial for the categorized dog. Typically, the a protein and fat content of the food composition will be adjusted based upon the robust or athletic category for a particular dog or dog type.
Patent AU-2007222689-B2 (AU)
Title: Substituted arylsulfonamides as antiviral agents
Inventor: DAGMAR KARTHAUS
IPC: C07D213/73
Filed: 2007-02-26
Granted: 2011-11-17
Abstract: The invention relates to substituted arylsulfonamides of formula (I) and to processes for preparing them, to their use for producing medicaments for the treatment and/or prophylaxis of diseases, particularly for use as antiviral agents, especially against cytomegaloviruses.
Patent AU-2007263013-B2 (AU)
Title: Process for the manufacture of 1,2-dichloroethane
Inventor: LEMPEREUR MICHEL
IPC: C07C17/02
Filed: 2007-06-21
Granted: 2012-03-22
Abstract: Process for the manufacture of DCE starting with a hydrocarbon source according to which: a) the hydrocarbon source is subjected to a first cracking step, namely a pyrolysis step carried out in at least one cracking furnace, thus producing a mixture of cracking products; b) said mixture of cracking products is subjected to a series of treatment steps making it possible to obtain a mixture of products containing ethylene and other constituents; c) said mixture of products containing ethylene is subjected to a first separation step S1 which consists of separating said mixture of products inside a column C1, into a fraction enriched with the compounds that are lighter than ethylene containing some of the ethylene (fraction A) and into a fraction F1; d) fraction F1 is subjected to a second separation step S2 which consists of separating fraction F1 inside a column C2 into a fraction F2 and into a heavy fraction (fraction C); e) fraction F2 is subjected to a third separation step S3 which consists of separating fraction F2 inside a column C3 into a fraction enriched with ethylene (fraction B) and into a fraction F3 mainly composed of ethane; f) fraction A is conveyed to a chlorination reactor and fraction B is conveyed to an oxychlorination reactor, reactors in which most of the ethylene present in fractions A and B is converted to1,2-dichloroethane; and g) the 1,2-dichloroethane obtained is separated from the streams of products derived from the chlorination and oxychlorination reactors.
Patent AU-2007283731-B2 (AU)
Title: Immunogenic peptides and their use in immune disorders
Inventor: SAINT-REMY JEAN-MARIE
IPC: A61K35/17
Filed: 2007-08-13
Granted: 2013-10-24
Abstract: The present invention provides novel peptides and homologues thereof. The peptides of the invention comprise (i) a T-cell epitope of an antigen (self or non-self) with a potential to trigger an immune reaction presented by a class Il major histocompatibility complex (MHC) determinant and recognised by CD4+ T cell more specifically of an allergen or auto-antigen, coupled, optionally through the use of a linker to (ii) an amino acid sequence having a reducing activity, such as a thioreductase sequence. The peptides of the invention have been shown to be useful a medicine, more in particular for the prevention or treatment of immune disorders, more specifically of allergic disorders or autoimmune diseases. The present invention thus provides for the use of said peptides for the manufacture of a medicament for the prevention or treatment of an immune disorder and further provides for methods of treatment or preventing immune disorders by using said peptides. The present invention also provides for compositions comprising said peptides.
Patent AU-2007296925-B2 (AU)
Title: Coating composition containing calcium hydrogenphosphate, processes for producing it, its use and substrates coated with it
Inventor: RADEMACHER JOSEF
IPC: C09D5/08
Filed: 2007-09-14
Granted: 2012-10-04
Abstract: The abstract relates to a coating composition comprising 25-55% by weight of one or more film formers, 2.5-55% by weight of one or more fillers, 0-10% by weight of one or more additives and 0-30% by weight of a solvent, based on the total weight of the coating composition. The composition contains calcium hydrogenphosphate in a proportion by mass of 2.5-20% by weight, preferably 5-15% by weight, particularly preferably 7.5-11% by weight, based on the total weight of the coating composition, as the or a filler. The invention further relates to processes for producing this coating composition, its use as surface coating in the vehicle sector and substrates produced using it.
Patent AU-2007301689-B2 (AU)
Title: Coupling assembly and protective ring therefor
Inventor: MCLAUGHLIN THOMAS KILPATRICK
IPC: F16L15/04
Filed: 2007-03-21
Granted: 2012-11-29
Abstract: A protective ring (40) for use in a coupling assembly (10), the coupling assembly comprising a coupling body (20) of generally cylindrical shape with a channel therethrough, each end of said coupling body having a thread (22, 24) for threaded mating with a tubular (32) so that the coupling assembly may provide a connection between two tubulars, the protective ring comprising a ring body for positioning adjacent an interior wall (26) of said coupling body (20) between the two ends thereof and located for contact by said two tubulars (32), said ring body being generally cylindrical and having a ring channel therethrough, characterised in that said protective ring comprises an energizing member (42), the arrangement being such that, in use, upon compression of said protective ring (40) between said two tubulars (32) said energizing member (42) urges said ring body against said interior wall (26) of said coupling body (20) whereby corrosive material is inhibited from contact therewith.
Patent AU-2007338407-B2 (AU)
Title: Cycloalkylamine substituted isoquinolone derivatives
Inventor: LOHN MATTHIAS
IPC: C07D217/24
Filed: 2007-12-19
Granted: 2012-08-02
Abstract: The invention relates to 6-substituted isoquinolone derivatives of the formula (I) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.
Patent AU-2007360114-B2 (AU)
Title: Belted absorbent article
Inventor: HERMANSSON KENT
IPC: A61F13/56
Filed: 2007-10-10
Granted: 2013-07-04
Abstract: The invention provides an absorbent article comprising a belt and an absorbent structure. The absorbent structure is fastened to the belt via an article fastening means having a form such that the article fastening means does not fold or bend upwards under the forces present when the diaper is assembled.
Patent AU-2008203489-B2 (AU)
Title: DisposaPak
Inventor: SMAL DARREN
IPC: B65D75/36
Filed: 2008-08-01
Granted: 2012-08-02
Abstract: DisposaPak Abstract A blister pack (1) to provide a disposable tamper evident dose administration aid. The pack (1) including a first sheet of card (5) having a plurality of holes (10) extending 5 through the first sheet. A plurality of pockets (15) to be located in use in respective holes to receive a medicament (30). A backing sheet (20) to be secured by an adhesive to the card to cover the holes and pockets. The backing sheet including a sheet of foil adhesively applied to the backing sheet adjacent the area of the holes and providing a tamper evident seal over the medicament. Figure 1 .Figure.2 Figure 2 met mng noonitsr ecm me tuem \NMENNNNNN'N ~'NN'X'~\ M ,. N'f' iXNN.N ink' ,- 'N"' ~' 4. '~" ~ NWM N 'NNN \.~*NNu XN, *A t ~'\ \'4N~ 4 tg . W N4N' N' y lxA Figure 5
Patent AU-2008207505-B2 (AU)
Title: Process for the preparation of dimethyl ether
Inventor: MADSEN JORGEN
IPC: C07C41/38
Filed: 2008-08-25
Granted: 2013-05-30
Abstract: Process for the preparation of dimethyl ether product by 5 catalytic conversion of synthesis gas to dimethyl ether comprising contacting a stream of synthesis gas comprising carbon dioxide with one or more catalysts active in the formation of methanol and the dehydration of methanol to dimethyl ether to form a product mixture comprising the 10 components dimethyl ether, methanol, carbon dioxide and un converted synthesis gas, washing the product mixture com prising carbon dioxide and unconverted synthesis gas in a scrubbing zone with a liquid solvent being rich in potas sium carbonate or amine and thereby selectively absorbing 15 carbon dioxide in the liquid solvent, subjecting the thus treated product mixture to a distillation step to separate methanol and water from dimethyl ether and unconverted syn thesis gas stream with a reduced content of carbon dioxide and separating the unconverted synthesis gas from the di 20 methyl ether product.
Patent AU-2008212016-B2 (AU)
Title: Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
Inventor: JUE-CHEN LIU
IPC: A61Q9/00
Filed: 2008-09-04
Granted: 2011-11-17
Abstract: Abstract The present invention utilizes natural and/or synthetic serine protease inhibitory agents or botanical extracts containing serine protease inhibitory activity, with or without the addition of one or 5 more isoflavones and/or additional natural extracts containing one or more isoflavones, and their ability to affect changes in mammalian hair growth, hair follicle and hair shaft size and hair pigmentation.
Patent AU-2008234374-B2 (AU)
Title: Method of determining risk of scoliosis
Inventor: MOREAU ALAIN
IPC: A23L33/00
Filed: 2008-03-31
Granted: 2013-05-23
Abstract: A method for determining the risk for developing a scoliosis comprising monitoring osteopontin (OPN) expression in a sample from a subject over time; wherein an OPN expression that increases in the subject sample over time is indicative that the subject is at risk for developing a scoliosis.
Patent AU-2008254899-B2 (AU)
Title: Medical connector with closeable male luer
Inventor: LOPEZ GEORGE A
IPC: A61M39/10
Filed: 2008-05-15
Granted: 2015-04-02
Abstract: A luer connector including a rigid housing having a first end and a second end. The housing further including a rigid tubular male portion at the first end, a rigid tubular female portion at the second end, and a longitudinal opening therethrough. The male portion is configured to be engageable with a female connector. The female portion is configured to be engageable with a male connector and to prevent the disengagement of the male connector from the female portion. In some embodiments, the female portion is configured to maintain a fixed rotational position when the male connector is being threaded therewith, but to rotate with the male connector once the male connector has become fully engaged with the female portion so as to prevent the male connector from becoming unthreaded from the female portion.
Patent AU-2008275601-B2 (AU)
Title: Method and apparatus for laryngeal elevator musculature rehabilitation
Inventor: POLANSKY RONDA
IPC: A61B5/04
Filed: 2008-07-11
Granted: 2012-03-29
Abstract: The current invention generally relates to a method of treating decreased laryngeal elevation. This invention further relates to the use of a neuro-orthotic device in combination with electrical stimulation of the submandibular muscles to treat laryngeal elevator musculature. This invention also relates to muscle re-education and rehabilitation using a neuro-orthotic device in combination with electrical stimulation of the submandibular muscles to treat laryngeal elevator musculature.
Patent AU-2008280929-B2 (AU)
Title: Fatty acid compositions having novel fatty acid rate
Inventor: OCHIAI MISA
IPC: C12P7/64
Filed: 2008-07-23
Granted: 2013-09-19
Abstract: Disclosed is a fatty acid composition having different fatty acid contents from those of a conventional one. Specifically disclosed is a fatty acid composition produced by culturing a host transformed with a recombinant vector which carries a nucleic acid comprising a nucleotide sequence encoding a protein having a nucleotide sequence depicted in SEQ ID NO:1 or an amino acid sequence depicted in SEQ ID NO:2 or a mutant of the protein having the equivalent functions. In the fatty acid contents of the fatty acid composition, at least one of the following contents and ratios i) to v) is higher than that in a culture product produced by culturing a host which is not transformed with the recombinant vector: i) the content of oleic acid; ii) the ratio of the content of oleic acid to the content of palmitic acid; iii) the ratio of the total content of stearic acid and oleic acid to the content of palmitic acid; iv) the ratio of the total content of stearic acid and oleic acid to the total content of palmitic acid and palmitoleic acid; and v) the content of an n-6 fatty acid.
Patent AU-2008301208-B2 (AU)
Title: A barbeque grill assembly
Inventor: LEAVENS BENJAMIN JOHN
IPC: A47J37/07
Filed: 2008-08-22
Granted: 2013-10-10
Abstract: A barbeque grill assembly (10) comprising a grill plate (12) and a cooking insert (14). The grill plate (12) has a substantially planar first cooking surface (26) with an opening (28) therein. The cooking insert (14) is adapted for releasable engagement with the opening (28) and has a substantially planar second cooking surface (42). The first cooking surface (26) and the second cooking surface (42) are non-parallel with respect to each other.
Patent AU-2008342535-B2 (AU)
Title: Silencing of polo-like kinase expression using interfering RNA
Inventor: JUDGE ADAM
IPC: C12N15/10
Filed: 2008-12-23
Granted: 2015-02-05
Abstract: The present invention provides compositions comprising interfering RNA (e.g., siRNA, aiRNA, miRNA) that target polo-like kinase 1 (PLK-1) expression and methods of using such compositions to silence PLK-1 expression. More particularly, the present invention provides unmodified and chemically modified interfering RNA molecules which silence PLK-1 expression and methods of use thereof. The present invention also provides serum-stable nucleic acid-lipid particles (e.g., SNALP) comprising an interfering RNA molecule described herein, a cationic lipid, and a non-cationic lipid, which can further comprise a conjugated lipid that inhibits aggregation of particles. The present invention further provides methods of silencing PLK-1 gene expression by administering an interfering RNA molecule described herein to a mammalian subject. The present invention additionally provides methods of identifying and/or modifying PLK-1 interfering RNA having immunostimulatory properties. Methods for sensitizing a cell such as a cancer cell to the effects of a chemotherapy drug comprising sequentially delivering PLK-1 interfering RNA followed by the chemotherapy drug are also provided.
Patent AU-2008343434-B2 (AU)
Title: DNS wildcard beaconing to determine client location and resolver load for global traffic load balancing
Inventor: CHRISTIAN MICHAEL
IPC: H04L45/24
Filed: 2008-12-12
Granted: 2012-02-23
Abstract: Techniques are described to determine clients residing behind LDNS resolvers. Web beacons instruct clients to retrieve zero-content images at unique hostnames. A request to the hostname is made by a client to an LDNS resolver. The LDNS sends the request to an authoritative server/beacon resolver for the hostname. The beacon resolver records the hostname with the LDNS resolver s IP address and responds with an IP address of a beacon collection server forwarded to the client by the LDNS. The client sends a request containing the unique hostname to the beacon collection server. The beacon collection server records the IP address of the client and hostname. An aggregation server collects data from the beacon resolver and beacon collection server. Using the hostnames as keys, IP addresses of clients are mapped to IP addresses of LDNS resolvers. Mapped data is exported to load balancing servers to determine routing.
Patent AU-2009211331-B2 (AU)
Title: Liquid formulation of FSH
Inventor: KOHLER ERICH
IPC: A61K38/24
Filed: 2009-02-09
Granted: 2014-07-03
Abstract: The present invention relates to a liquid pharmaceutical composition comprising a follicle stimulating hormone polypeptide and benzalkonium chloride and benzyl alcohol as preservatives. The composition further comprises optionally one or more other pharmaceutically acceptable excipients. In one embodiment, the composition contains methionine as an antioxidant. The composition shows a good storage stability and is especially useful for the prophylaxis and treatment of disorders and medical indications where follicle stimulating hormone preparations are considered as useful remedies.
Patent AU-2009212747-B2 (AU)
Title: Engineered antibody constant domain molecules
Inventor: DIMITROV DIMITER S
IPC: C07K19/00
Filed: 2009-01-30
Granted: 2013-11-07
Abstract: Described herein are engineered antibody constant domain molecules, such as CH2 or CH3 domain molecules, comprising at least one mutation, or comprising at least one complementarity determining region (CDR), or a functional fragment thereof, engrafted in a loop region of the CH2 domain. The CH2 domain molecules described herein are small, stable, soluble, exhibit little to no toxicity and are capable of binding antigen.